Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Medicare study evaluates impact of U.S. Hospital Readmissions Reduction Program

Key clinical point: The U.S. Hospital Readmissions Reduction Program did not lead to harm through inappropriate triage of patients at high risk to observation units and the emergency department.

Major finding: Between 2008 and 2016, risk adjusted mortality increased annually by 0.05% only for heart failure, while it decreased by 0.06% for acute MI, and did not significantly change for pneumonia.

Study details: A retrospective cohort study of Medicare claims data from 2008 to 2016.

Disclosures: Dr. Khera disclosed that he is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health. His coauthors reported having numerous disclosures.

Citation:

Khera et al. BMJ 2020 Jan. 15; doi:10.1136/bmj.l6831.